Suppr超能文献

[一种抗迷走神经药物和一种β2拟交感神经药物对哮喘患者呼吸功能的对比研究]

[Comparative study of a vagolytic and a beta 2 sympathomimetic drug on the respiratory function of the asthmatic patient].

作者信息

Ramonatxo M, Prefaut C, Tronc J F, Michel F B, Chardon G

出版信息

Poumon Coeur. 1978;34(2):95-9.

PMID:149968
Abstract

The authors compared the effects of a synthetic vagolytic drug, the SCH 1000, and a beta2 sympathicomimetic one (Fenoterol) in two groups of control children (n = 11) and two groups of asthmatic children (n = 23). They studied the following parameters, flow volumes curves, steady state lung diffusing capacity and the blood gases. No difference of efficiency was found between the two types of bronchodilators although the graphic modification of flow volumes curves was different after Fenoterol and after SCH 1000. The modifications consisted in a great improvement in instantaneous flow, a decrease in diffusion capacity and an increase of the Pa O2 significant in the group of asthmatic children after Fenoterol.

摘要

作者比较了一种合成的抗迷走神经药物SCH 1000和一种β2拟交感神经药物(非诺特罗)对两组对照儿童(n = 11)和两组哮喘儿童(n = 23)的影响。他们研究了以下参数:流量容积曲线、稳态肺弥散能力和血气。尽管非诺特罗和SCH 1000给药后流量容积曲线的图形变化不同,但两种支气管扩张剂之间未发现疗效差异。这些变化包括瞬间流量大幅改善、弥散能力降低以及非诺特罗给药后哮喘儿童组的动脉血氧分压(Pa O2)显著升高。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验